FIRST-IN-CLASS ANTIBODIES
Our monoclonal antibodies are designed to target key cellular pathways that enable cancer to grow and proliferate, known as cancer cell signaling, and pathways that help the body’s immune system to identify and treat cancer.
BETTER PATIENT OUTCOMES
Therapies targeting cancer cell signaling and T cells offer new options for patients with cancer. We are committed to making a difference in the lives of cancer patients.
47 Thorndike Street, Suite B1-1
Cambridge, MA 02141 USA
Phone: +1-617-714-0360
If you are interested in business development, e-mail us at bd@leaptx.com